While the incidence of influenza-associated neuropsychiatric events in children in the United States is unknown, the controversy over the use of a common antiviral medication typically administered to ...

Event rates were lower during oseltamivir-treated influenza periods and posttreatment periods compared to untreated influenza. HealthDay News — Oseltamivir treatment during influenza episodes is ...

Treatment with the antiviral oseltamivir (Tamiflu) was tied to a reduced risk of serious neuropsychiatric events in children and adolescents, an analysis of Medicaid beneficiaries in Tennessee ...

Compared to the nicotine patch and a placebo, the smoking cessation aids varenicline (marketed as Chantix in the U.S.) and bupropion (Zyban) do not show a significant increase in neuropsychiatric ...

Influenza, and not the antiviral treatment for it, is responsible for increased neuropsychiatric risks in pediatric patients, new research suggested. The risk for these events was about 50% lower in ...

For decades, medical professionals debated whether a common antiviral medication used to treat flu in children caused neuropsychiatric events or if the infection itself was the culprit. Now ...

ORLANDO -- Neuropsychiatric events among children after starting montelukast (Singulair) for allergy and asthma treatment were more likely for those who had a history of comorbid psychiatric ...

New research suggests that the commonly-prescribed antiviral drug, oseltamivir, marketed as ‘Tamiflu’, does not cause serious neuropsychiatric symptoms, and that these symptoms are instead caused by ...

Compared with untreated flu, oseltamivir treatment reduced the risk of serious neuropsychiatric events in children. Prescribing information for oseltamivir carries warnings about abnormal behavior in ...

Principal investigator James Antoon, MD, PhD, MPH, assistant professor of Pediatrics in the Division of Pediatric Hospital Medicine at Monroe Carell. For decades, medical professionals debated whether ...